NCT00538811View on ClinicalTrials.gov

Interferon-gamma With Interferon Alpha and Ribavirin for Hepatitis C Non-responders

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

Not specified

Conditions
Hepatitis CGenotype 3Non-respondersRelapsers
Interventions
DRUG

interferon alpha-2b, ribavirin, interferon-gamma,

DRUG

interferon alpha-2b, ribavirin, amantadine

Trial Locations (2)

74800

Medicare Clinic, Karachi

The Aga Khan University Hospital, Karachi

All Listed Sponsors
lead

Aga Khan University

OTHER

NCT00538811 - Interferon-gamma With Interferon Alpha and Ribavirin for Hepatitis C Non-responders | Biotech Hunter | Biotech Hunter